These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20236606)

  • 21. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
    Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
    Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
    Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
    Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of Microbubbles for Targeted Ultrasound Contrast Imaging: Practical Translation Considerations.
    Unnikrishnan S; Du Z; Diakova GB; Klibanov AL
    Langmuir; 2019 Aug; 35(31):10034-10041. PubMed ID: 30509068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
    Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
    Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bubble sorting in pinched microchannels for ultrasound contrast agent enrichment.
    Kok MP; Segers T; Versluis M
    Lab Chip; 2015; 15(18):3716-22. PubMed ID: 26223966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
    Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
    Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Targeting Microbubble for Ultrasound Molecular Imaging.
    Yeh JS; Sennoga CA; McConnell E; Eckersley R; Tang MX; Nourshargh S; Seddon JM; Haskard DO; Nihoyannopoulos P
    PLoS One; 2015; 10(7):e0129681. PubMed ID: 26161541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended Lifetime In Vivo Pulse Stimulated Ultrasound Imaging.
    Wang J; Barback CV; Ta CN; Weeks J; Gude N; Mattrey RF; Blair SL; Trogler WC; Lee H; Kummel AC
    IEEE Trans Med Imaging; 2018 Jan; 37(1):222-229. PubMed ID: 28829305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of tissue perfusion by contrast-enhanced ultrasound.
    Quaia E
    Eur Radiol; 2011 Mar; 21(3):604-15. PubMed ID: 20927527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of ultrasound contrast material. An in vitro feasibility study.
    Klibanov AL; Hughes MS; Marsh JN; Hall CS; Miller JG; Wible JH; Brandenburger GH
    Acta Radiol Suppl; 1997; 412():113-20. PubMed ID: 9240089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vivo validation of the application of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d ultrasound.
    Gessner RC; Streeter JE; Kothadia R; Feingold S; Dayton PA
    Ultrasound Med Biol; 2012 Apr; 38(4):651-60. PubMed ID: 22341052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monodisperse versus Polydisperse Ultrasound Contrast Agents: In Vivo Sensitivity and safety in Rat and Pig.
    Helbert A; Gaud E; Segers T; Botteron C; Frinking P; Jeannot V
    Ultrasound Med Biol; 2020 Dec; 46(12):3339-3352. PubMed ID: 33008649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
    Puett C; Sheeran PS; Rojas JD; Dayton PA
    Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kidney: imaging with microbubble contrast agents.
    Correas JM; Claudon M; Tranquart F; Hélénon AO
    Ultrasound Q; 2006 Mar; 22(1):53-66. PubMed ID: 16641794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
    Rapoport N; Gao Z; Kennedy A
    J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of bound microbubbles in ultrasound molecular imaging.
    Daeichin V; Akkus Z; Skachkov I; Kooiman K; Needles A; Sluimer J; Janssen B; Daemen MJ; van der Steen AF; de Jong N; Bosch JG
    IEEE Trans Ultrason Ferroelectr Freq Control; 2015 Jun; 62(6):1190-200. PubMed ID: 26067053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipid Oxygen Microbubbles for Image-Guided Therapy.
    Reusser TD; Song KH; Ramirez D; Benninger RK; Papadopoulou V; Borden MA
    Nanotheranostics; 2020; 4(2):83-90. PubMed ID: 32190535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
    Schutt EG; Klein DH; Mattrey RM; Riess JG
    Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.